AMGN Chart AMGN data by YCharts

Amgen ( AMGN): Cramer said this drug maker delivered stellar earnings, yet saw its shares fall with the rest of the market, which is why it should be bought into weakness.

If you liked this article you might like

Wall Street Overlooks Trump's North Korea Threats to Hit New Records

Best Buy Disappointment Sends Retailers Into a Spin

Stocks on Track for Records Even as Trump Goes After North Korea

5 Stores With the Best Return Policies

Amazon Could Kill 400 of the 1,200 Malls in the United States -- Here's How